These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 218824)

  • 21. The pathophysiological role of renal dopamine, kallikrein kinin and prostaglandin systems in essential hypertension.
    Iimura O; Shimamoto K; Ura N; Nakagawa M; Nishimiya T; Ando T; Yamaguchi Y; Masuda A; Ogata H; Saito S
    Agents Actions Suppl; 1987; 22():247-56. PubMed ID: 3324711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the converting enzyme inhibitor SQ-20881 on urinary excretion of prostaglandin E2 in the rat: influence of pretreatment with deoxycorticosterone.
    Barr JG; Diz D; Kauker ML; Nasjletti A
    J Pharmacol Exp Ther; 1980 Oct; 215(1):172-5. PubMed ID: 6161243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Iimura O; Shimamoto K
    Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of urinary pH and urine flow rate on prostaglandin E2 and kallikrein excretion by the conscious dog.
    Filep J; Földes-Filep E
    J Physiol; 1987 Feb; 383():1-8. PubMed ID: 2821232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prostaglandin and kallikrein-kinin systems in mineralocorticoid escape.
    Zipser RD; Zia P; Stone RA; Horton R
    J Clin Endocrinol Metab; 1978 Nov; 47(5):996-1001. PubMed ID: 263798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of mineralocorticoids, renal prostaglandins and the renal kallikrein-kinin system.
    Nasjletti A; Colina-Chourio J
    Fed Proc; 1976 Feb; 35(2):189-93. PubMed ID: 765163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of captopril on the urinary excretion of prostanoids and kallikrein in spontaneously hypertensive rats.
    Säynävälammi P
    Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):285-90. PubMed ID: 3541494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin/kinin activity related to changed renal compliance after bumetanide in dogs.
    Olsen UB
    Acta Pharmacol Toxicol (Copenh); 1977 Mar; 40(3):430-8. PubMed ID: 576566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal vasoactive hormones in scleroderma (progressive systemic sclerosis).
    Oliver JA; Vinci JM; Bowden RE; Weinberger AB; Baer L; Keiser HR; Cannon PJ
    Nephron; 1981; 29(3-4):110-6. PubMed ID: 7035981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal kinin-prostaglandin relationship: implications for renal function.
    Nasjletti A; Malik KU
    Kidney Int; 1981 Jun; 19(6):860-8. PubMed ID: 6167754
    [No Abstract]   [Full Text] [Related]  

  • 31. Interrelationships between the renal kallikrein-kinin and prostaglandin systems in furosemide-induced diuresis.
    Ayano Y; Yamasaki K; Soejima H; Ikegami K
    Urol Int; 1984; 39(1):52-7. PubMed ID: 6587655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Responses of the renin-angiotensin system and kallikrein-kinin system to sodium and converting enzyme inhibitor (SQ 14,225).
    Matthews PG; Johnston CI
    Adv Exp Med Biol; 1979; 120B():447-57. PubMed ID: 390990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of angiotensin converting enzyme inhibitors MK 421, SA 446 and captopril on renal prostaglandin E and kinins in conscious normotensive rats.
    Yasujima M; Abe K; Tanno M; Kohzuki M; Kasai Y; Kanazawa M; Omata K; Sato M; Takeuchi K; Yoshinaga K
    Clin Exp Hypertens A; 1987; 9(2-3):401-4. PubMed ID: 3038402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.
    Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K
    J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of Bartter's syndrome--special reference to tubular function, the prostaglandin and the kallikrein-kinin system in the kidney].
    Ishiyama N; Kikuchi K; Oimatsu H; Nakao T; Takigami Y; Kondo A; Iimura O; Yamaguchi J
    Nihon Jinzo Gakkai Shi; 1985 Jan; 27(1):113-21. PubMed ID: 3847529
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on renomedullary prostaglandin and renal kallikrein-kinin system in hypertension.
    Abe K; Seino M; Yasujima M; Chiba S; Sakurai Y
    Jpn Circ J; 1977 Aug; 41(8):873-80. PubMed ID: 909128
    [No Abstract]   [Full Text] [Related]  

  • 37. The renal kallikrein-kinin system in various types of diuresis and under the effects of inhibitors of prostaglandin synthesis in rats.
    Shkhvatsabaya IK; Nekrasova AA; Zharova EA
    Cor Vasa; 1978; 20(6):400-8. PubMed ID: 747924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a kinin antagonist on renal function in rats.
    Nakagawa M; Stewart JM; Vavrek RJ; Nasjletti A
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F643-8. PubMed ID: 1690517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary prostaglandin and kallikrein excretion are not flow dependent in the rat.
    Fejes-Tóth G; Náray-Fejes-Tóth A; Rigter B; Frölich JC
    Prostaglandins; 1983 Jan; 25(1):99-103. PubMed ID: 6405455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Function of the kallikrein-kinin and prostaglandin systems of the kidneys in patients with chronic pyelonephritis].
    Panfilov IuA; Kriukov NN; Baĭbursian ED
    Urol Nefrol (Mosk); 1989; (1):7-9. PubMed ID: 2718290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.